Spark Investment Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Spark Investment Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,100	Closed	-$198K	–	756
2019 Q1	$198K	Buy	15,100 +2,265	+18%	+$33K	0.01%	505
2018 Q4	$185K	Buy	12,835 +1,867	+17%	+$30.4K	0.01%	507
2018 Q3	$195K	Buy	+10,968	New	+$190K	0.01%	569
2018 Q2	–	Sell	-10,000	Closed	-$191K	–	755
2018 Q1	$191K	Sell	10,000 -10,400	-51%	-$225K	0.01%	511
2017 Q4	$468K	Buy	20,400 +6,500	+47%	+$208K	0.03%	463
2017 Q3	$511K	Buy	+13,900	New	+$518K	0.03%	485

Other funds holding OPNT

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 28.91% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Spark Investment Management's OPNT Position: Q2 2019 in Review

Spark Investment Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2019, closing a stake of 15,100 shares — an estimated $198K sold.

Spark Investment Management first reported a position in OPNT in Q3 2017 and held it in 6 quarters. The position peaked at $511K in Q3 2017. 15 funds tracked by Wall St. Rank hold OPNT as of Q2 2019.

Spark Investment Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Spark Investment Management sold 15,100 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $198K.
Spark Investment Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
Spark Investment Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $511K in Q3 2017.
15 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.